Cima is a university research institute of the University of Navarra. Its mission is to carry out translational research to a high standard of excellence, based on novel biological knowledge and aimed at finding therapeutic solutions to patients' needs.
Cima's vision is to be an international reference center in biomedical research, valued for the relevance of its scientific discoveries and for the applicability of some of the products of its research in improving the health of patients, combining, therefore, the generation of knowledge with innovation and medical impact on society.
Company Details
- Employees
- 300
- Founded
- -
- Address
- Pio Xii 55, Pamplona,navarra 31008,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.cima.cun.es
- Keywords
- Investigación biomédica, Innovación y desarrollo, Investigación Traslacional, Parkinson, Cáncer, Mieloma Múltiple, Investigación Oncológica, Investigación Cáncer Hematológico, Terapia Génica.
- HQ
- Pamplona, Navarra
Cima Universidad De Navarra Questions
Cima Universidad De Navarra's website is http://www.cima.cun.es
Cima Universidad De Navarra's LinkedIn profile is https://es.linkedin.com/company/cimaunav
Cima Universidad De Navarra has
300 employees.
View email and phone details for 300
employees at Cima Universidad De Navarra.
Cima Universidad De Navarra's industry is
Research Services
Cima Universidad De Navarra's top competitors are
Clínica Universidad De Navarra,
Navarra Health Cluster,
Navarrabiomed, Biomedical Research Centre,
Instituto De Investigación Sanitaria De Navarra (Idisna),
Viralgen,
Cinfa,
3pbiovian,
3p Biopharmaceuticals,
Quirónsalud,
Servicio De Prácticas Y Empleo De La Universidad De Navarra.
Cima Universidad De Navarra's categories are Research Services
Cima Universidad De Navarra's founding year is 2004
